Results 201 to 210 of about 817,148 (269)

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan   +5 more
wiley   +1 more source

Investments in Childhood Community Resources and Subsequent Adult Health Outcomes.

open access: yesJAMA Netw Open
La Charite J   +9 more
europepmc   +1 more source

International variation in child healthcare practices and implications for childhood cancer diagnosis: a scoping review and cross-country clinician survey. [PDF]

open access: yesEur J Pediatr
Lopez-Cortes A   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy